Home > Quotes > ANTH
ANTH

Anthera Pharmaceuticals, Inc. Quote & Summary Data

$3.7
*  
0.10
2.63%
Get ANTH Alerts
*Delayed - data as of Apr. 29, 2016  -  Find a broker to begin trading ANTH now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Anthera Pharmaceuticals, Inc. Intraday Chart




News for ANTH

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 3.86 $ 11.65
Low $ 3.60 $ 2.282

The current last sale of $3.70 is 62.14% Higher thanthe 52 week low.

P/E Ratio

Company Description (as filed with the SEC)

Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. We currently have two Phase 3 product candidates, liprotamase also known as SollpuraTM and blisibimod. We licensed liprotamase from Eli Lilly & Co ("Eli Lilly") in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy ("PERT") intended for the treatment of patients with Exocrine Pancreatic Insufficiency ("EPI"), often seen in patients with cystic fibrosis and other conditions. We licensed blisibimod from Amgen, Inc. ("Amgen") in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including systemic lupus erythematosus ("SLE"), or lupus, Immunoglobulin A nephropathy, or IgA nephropathy, lupus nephritis, and others.  ... More ...  

Risk Grade

Where does ANTH fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?